Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „treated“
Suchtreffer
Begriffe & Kennungen
Abilify Maintena · 4.8 · Data from an open-label study of patients treated with Abilify Maintena 960 mg, showed minimal change from bas
Eintrag öffnenAbiraterone Mylan · 4.8 · Hepatotoxicity Hepatotoxicity with elevated ALT, AST and total bilirubin has been reported in patients treated
Eintrag öffnenAbiraterone Mylan · 4.8 · The following CTCAE (version 4.0) Grade 3 adverse reactions occurred in patients treated with abiraterone acet
Eintrag öffnenAblymico · 4.8 · Acute renal failure In patients treated with GLP-1 receptor agonists, there have been reports of acute renal f
Eintrag öffnenAblymico · 4.8 · Hypoglycaemia in patients with type 2 diabetes mellitus treated with insulin In a clinical trial in overweight
Eintrag öffnenAblymico · 4.8 · Injection site reactions Injection site reactions have been reported in patients treated with liraglutide. The
Eintrag öffnenAblymico · 4.8 · Patients ≥ 65 years of age may experience more gastrointestinal effects when treated with liraglutide.
Eintrag öffnenAblymico · 4.8 · Tachycardia In clinical trials, tachycardia was reported in 0.6 % of patients treated with liraglutide and in
Eintrag öffnenAbraxane · 4.8 · 14 22 cases of sepsis reported in patients treated with Abraxane in combination with gemcitabine, 5 had a fata
Eintrag öffnenAbraxane · 4.8 · Abraxane monotherapy-metastatic breast cancer Alopecia was observed in > 80% of the patients treated with Abra
Eintrag öffnenAbraxane · 4.8 · Abraxane/carboplatin For non-small cell lung cancer patients treated with Abraxane and carboplatin, the median
Eintrag öffnenAbraxane · 4.8 · Abraxane/gemcitabine For patients treated with Abraxane in combination with gemcitabine, the median time to fi
Eintrag öffnenAbraxane · 4.8 · Adverse reactions were assessed in 229 patients with metastatic breast cancer who were treated with 260 mg/m2
Eintrag öffnenAbraxane · 4.8 · Adverse reactions were assessed in 421 patients with metastatic pancreatic cancer who were treated with Abraxa
Eintrag öffnenAbraxane · 4.8 · Adverse reactions were assessed in 514 patients with non-small cell lung cancer who were treated with Abraxane
Eintrag öffnenAbraxane · 4.8 · Thrombocytopeniab,c 74 13 70 9 a 405 patients assessed in Abraxane/gemcitabine-treated group b 388 patients as
Eintrag öffnenAdcetris · 4.8 · 14 The safety data in patients retreated with ADCETRIS (SGN35-006, see section 5.1) were consistent with those
Eintrag öffnenAdcetris · 4.8 · In patients with relapsed or refractory HL or sALCL who were retreated with ADCETRIS (SGN35-006), the majority
Eintrag öffnenAdcetris · 4.8 · In the studies of ADCETRIS as combination therapy in 662 patients with previously untreated advanced HL (C2500
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · 10 were treated with placebo, for 24 weeks. The most common AEs, occurring in ≥ 2 patients treated with tadala
Eintrag öffnen